This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Clarkson, B. D. Search for Related Content PubMed PubMed Citation Articles by Clarkson, B. D.

The Elusive Goal: Presidential Address¹

Laboratory of Hematopoietic Cell Kinetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

The advances in treatment of cancer which have taken place during the last 25 years are quite remarkable considering that therapists have had at their disposal only what has been called half-way technology. About 45% of serious cancers are now curable with surgery, radiotherapy, and chemotherapy or combined forms of these treatments, but prospects for developing curative therapy for the other half of cancer patients are not bright unless more selective forms of treatment can be developed. Recent advances in basic biology have opened doors to marvelous new research opportunities hardly imaginable a few years ago, and the time is opportune to make a concerted effort to develop more selective treatment.

¹ Supported in part by Grants awarded from the National Cancer Institute (NIH-CA-19117; CA-20194; CA-08748), The American Cancer Society (ACS-CH-6L), and the United Leukemia Fund. Presented on April 28, 1981, at the Seventy-Second Annual Meeting of the American Association for Cancer Research, Washington, D. C.